Evidence by drug
Metronomic cyclophosphamide
267 studies and 126 trials indexed. 16 trials are recruiting or about to start.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
Trials recruiting or starting soon
- RecruitingEarly phase 1CanadaNCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- RecruitingPhase 1United StatesNCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RecruitingPhase 2Austria, Czechia, Denmark, and 5 moreNCT01356290Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsMedical University of Vienna
- RecruitingPhase 2ChinaNCT06854250Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate CancerSun Yat-sen University
- RecruitingPhase 1, Phase 2Denmark, France, Italy, and 3 moreNCT02813135European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory TumorsGustave Roussy, Cancer Campus, Grand Paris
- RecruitingPhase 2ChinaNCT06771609Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 2United StatesNCT06771544Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory MelanomaUniversity of California, Irvine
- RecruitingPhase 2United StatesNCT04469530Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid TumorsEmory University
- RecruitingPhase 2United StatesNCT06085742BRE-08 Phase II Study of CMC Regimen for Early Stage Breast CancerUniversity of Illinois Chicago
- RecruitingPhase 2RussiaNCT07130032Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeEuroCityClinic LLC
- RecruitingPhase 2ItalyNCT06800391Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei PatientsFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RecruitingPhase 2ItalyNCT03971045Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerEuropean Institute of Oncology
- RecruitingEarly phase 1United StatesNCT02446431Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of RecurrenceMiller Children's & Women's Hospital Long Beach
- Not yet recruitingPhase 2EgyptNCT07361133Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNational Cancer Institute, Egypt
- Not yet recruitingPhase 2NCT07489300Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal CancerSecond Affiliated Hospital, Zhejiang University, School of Medicine
- Not yet recruitingPhase 2NCT06229067Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences
Newest studies
- StudyCancers (Basel)2026 Oct 30Real-World Activity and Safety of Metronomic Cyclophosphamide in Advanced Soft-Tissue Sarcoma: The Multicenter MeRCY Study.Bolognini C, et al.
- StudyOncol Ther2026 Oct 20Multimodal Combination Treatment in a Patient-Centered Approach is Associated with Improved Outcome in Relapsed/Refractory Sarcomas in Children: A Comparative Single-Institution Real-World Analysis.Kyr M, et al.
- StudyMol Carcinog2026 Oct 6Cooperative Modulation of the NF-κB and p53 Pathways by Metronomic Cyclophosphamide and Metformin Inhibits Ehrlich Carcinoma Progression and Enhances Systemic Immunity.Zaki HM, et al.
- StudyGynecol Oncol2026 Oct 1Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.Smith G, et al.
- StudyProstate2026 OctEvaluation of [(225)Ac]Ac-PSMA-617 vis-a-vis Rechallenge [(177)Lu]Lu-PSMA-617 PRLT Versus Cabazitaxel or Oral Metronomic Chemotherapy in mCRPC: An Observational Analysis of Outcome and Toxicity Profiles in a Real-World Clinical Scenario.Agrawal R, et al.
- Systematic reviewCancer Treat Rev2026 SepVinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.Haveman LM, et al.
- StudyFront Pharmacol2026Hematopoietic and T-lymphopoiesis-stimulating effects of a fluorinated pyrazolopiperidine β-cyclodextrin complex in cyclophosphamide-induced hematopoietic suppression.Ten A, et al.
- StudyCancers (Basel)2026 Jul 17Adverse Events as a Surrogate of Sufficient Pharmacological Exposure in Metronomic Combination Chemotherapy: Extended Real-World Cohort Analysis of the FulVEC Regimen in Metastatic ER+/HER2- Breast Cancer.Buda-Nowak A, et al.
- StudyIndian J Hematol Blood Transfus2026 JulReal Egyptian Single-Center Experience in Mantle Cell Lymphoma Diagnosis and Management.Jamal E, et al.
- StudyPediatr Blood Cancer2026 JulSafety and Efficacy of Vinorelbine and Continuous Low-Dose Cyclophosphamide Chemotherapy in Japanese Pediatric Patients With Relapsed or Refractory Rhabdomyosarcoma.Yanai R, et al.
- StudyCancers (Basel)2026 May 28Prognostic Circulating Cytokine Panels for Metronomic Chemotherapy in Metastatic Gastrointestinal Cancer: Exploratory Pharmacodynamic Biomarker Analysis of the Phase II COMET Trial.Manca ML, et al.
- StudyInt J Pharm2026 May 5Hospital 3D-printed cyclophosphamide printlets for paediatric patients.Boucida M, et al.
- ReviewTransl Cancer Res2026 Apr 30Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review.Li S, et al.
- StudyOncologist2026 Apr 10Impact of geriatric covariates on metronomic cyclophosphamide efficacy and tolerance-the CHEMETROLD study.Griffe C, et al.
- StudyIndian J Surg Oncol2026 AprEfficacy of Metronomic Oral Capecitabine, Methotrexate and Cyclophosphamide in Locally Advanced Operable Oral Cavity Squamous Cell Carcinoma - A Phase II Study.Chanda S, et al.
- StudyVaccines (Basel)2026 Feb 21Evaluation of Antibodies Induced by Melanoma Helper Peptide Vaccine and Their Modulation by Vaccine Adjuvants.Ashkani EG, et al.
- StudybioRxiv2026 Jan 8Indomethacin exerts both cyclooxygenase inhibition-dependent and independent mechanisms to enhance chemo-immunotherapy in mice.Okoko OD, et al.
- Case reportContemp Oncol (Pozn)2026Myelodysplastic syndrome after maintenance treatment with metronomic cyclophosphamide: weighing prolonged stable disease against late toxicity.Carvalho SN, et al.
- Clinical trialInt J Cancer2026 Jan 1Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancers.Spehner L, et al.
- StudyOncol Res Treat2026Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic.Krajnak S, et al.
- StudyESMO Gastrointest Oncol2025 DecRegorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.El Kaddissi A, et al.
- Case reportCase Rep Oncol2026 Jan-DecNovel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression.Patel VM, et al.
- Case reportInt Med Case Rep J2025Metronomic Chemotherapy in the Treatment of Infantile Parotid Hemangioma - A Case Report.Dadaboev A, et al.
- StudyMolecules2025 Sep 12Synthesis, Clastogenic and Cytotoxic Potential, and In Vivo Antitumor Activity of a Novel N-Mustard Based on Indole-3-carboxylic Acid Derivative.Filimonova M, et al.
- StudyInt J Mol Sci2025 Sep 1M344 Suppresses Histone Deacetylase-Associated Phenotypes and Tumor Growth in Neuroblastoma.Brumfield GL, et al.
- Case reportFront Oncol2025Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical response.Dai G, et al.
- StudyAnticancer Drugs2025 Aug 1Efficacy of immune checkpoint inhibitors rechallenge and metronomic cyclophosphamide with or without bevacizumab in metastatic nonsmall cell lung cancer.Musaelyan AA, et al.
- ReviewInt J Mol Sci2025 Jul 4Effects of the Alkylating Agent Cyclophosphamide in Potentiating Anti-Tumor Immunity.Gephart BD, et al.
- Case reportGynecol Oncol Rep2025 AugEfficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: a retrospective observational study.Steck AR, et al.
- Clinical trialPediatr Blood Cancer2025 JulResults of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval-Compressed Multiagent and Metronomic Chemotherapy.Rose A, et al.
- StudyBull Cancer2025 Jun[Extra-pulmonary metastatic Ewing sarcoma: The French GroupOs diagnostic and therapeutic recommendations].Winter S, et al.
- StudyClin Breast Cancer2025 JunOptimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.Trapani D, et al.
- StudyInt Cancer Conf J2025 JulLow-dose oral cyclophosphamide with or without bevacizumab treatment in patients with recurrent ovarian and cervical cancer before best supportive care.Kawaguchi Y, et al.
- StudybioRxiv2025 May 6Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.Pedroza DA, et al.
- StudyNeurooncol Adv2025 Jan-DecFeasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.Maureille A, et al.
- Clinical trialESMO Open2025 AprMultimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial.Merlano MC, et al.
- StudyBreast2025 AprCorrigendum to "Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trial" [The Breast 78 (2004) 103795].Larsson F K, et al.
- Phase 3 trialPediatr Blood Cancer2025 AprResults of the Latin American Pediatric Oncology Group (GALOP-2011) Trial for Patients With Localized Ewing Sarcoma: A Multicentric Study of Interval-Compressed Multiagent Chemotherapy.Gregianin LJ, et al.
- ReviewTher Adv Med Oncol2025Impact of systemic anticancer therapy timing on cancer vaccine immunogenicity: a review.Gomez-Randulfe I, et al.
- Clinical trialNat Commun2025 Feb 20Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.Piffoux M, et al.
